HONG KONG, Jun 4, 2026 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK) announced that it has entered into an exclusive licensing and collaboration agreement with Travere Therapeutics, Inc. (NASDAQ: TVTX) for the development and commercialization of civorebrutin […]